Works matching IS 11707690 AND DT 2023 AND VI 41 AND IP 4

Results: 9

Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review.

Published in:

2023

By:

Li, Nannan;
Beaudart, Charlotte;
Cauley, Jane A.;
Ing, Steven W.;
Lane, Nancy E.;
Reginster, Jean‑Yves;
Silverman, Stuart;
Singer, Andrea J.;
Hiligsmann, Mickaël

Publication type:

Correction Notice

Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Published in:

PharmacoEconomics, 2023, v. 41, n. 4, p. 353, doi. 10.1007/s40273-023-01247-w

By:

Al Khayat, Mohamed N. M. T.;
Armstrong, Nigel;
Howick, Jeremy;
O'Meara, Susan;
Posadzki, Pawel;
Ryder, Steve;
Ahmadu, Charlotte;
Konings, Stefan R. A.;
Postma, Maarten J.;
Duffy, Steven;
Wolff, Robert F.;
van Asselt, Antoinette D. I.

Publication type:

Article

The Use of a Discrete Choice Experiment Including Both Duration and Dead for the Development of an EQ-5D-5L Value Set for Australia.

Published in:

PharmacoEconomics, 2023, v. 41, n. 4, p. 427, doi. 10.1007/s40273-023-01243-0

By:

Norman, Richard;
Mulhern, Brendan;
Lancsar, Emily;
Lorgelly, Paula;
Ratcliffe, Julie;
Street, Deborah;
Viney, Rosalie

Publication type:

Article

Modelling the Cost-Effectiveness of Diagnostic Tests.

Published in:

PharmacoEconomics, 2023, v. 41, n. 4, p. 339, doi. 10.1007/s40273-023-01241-2

By:

Snowsill, Tristan

Publication type:

Article

Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review.

Published in:

PharmacoEconomics, 2023, v. 41, n. 4, p. 363, doi. 10.1007/s40273-022-01239-2

By:

Li, Nannan;
Beaudart, Charlotte;
Cauley, Jane A.;
Ing, Steven W.;
Lane, Nancy E.;
Reginster, Jean-Yves;
Silverman, Stuart;
Singer, Andrea J.;
Hiligsmann, Mickaël

Publication type:

Article

Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations.

Published in:

PharmacoEconomics, 2023, v. 41, n. 4, p. 395, doi. 10.1007/s40273-022-01238-3

By:

Behr, Carina M.;
Oude Wolcherink, Martijn J.;
IJzerman, Maarten J.;
Vliegenthart, Rozemarijn;
Koffijberg, Hendrik

Publication type:

Article

Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis.

Published in:

PharmacoEconomics, 2023, v. 41, n. 4, p. 457, doi. 10.1007/s40273-022-01237-4

By:

Thokala, Praveen;
Hnynn Si, Pann Ei;
Hernandez Alava, Monica;
Sasso, Alessandro;
Schaufler, Thilo;
Soro, Marco;
Fotheringham, James

Publication type:

Article

Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario.

Published in:

PharmacoEconomics, 2023, v. 41, n. 4, p. 413, doi. 10.1007/s40273-022-01236-5

By:

Kim, John J.;
Alsabbagh, Wasem;
Wong, William W. L.

Publication type:

Article

Identifying Attributes for a Value Assessment Framework in China: A Qualitative Study.

Published in:

PharmacoEconomics, 2023, v. 41, n. 4, p. 439, doi. 10.1007/s40273-022-01235-6

By:

Zhang, Mengmeng;
Bao, Yun;
Yang, Yi;
Kimber, Melissa;
Levine, Mitchell;
Xie, Feng

Publication type:

Article